why choose us

300×250 Ad Slot

Research Article: A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis

Date Published: 2023-12-08

Introduction:
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies that act against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK), or other AChR-related proteins on the postsynaptic membrane of the neuromuscular junction, leading to muscle weakness and fatigability. , Based on the age at onset, with and years set as the limits, MG patients can be categorized into three different age-based subgroups: early-onset MG (< years), late-onset MG (? and < years), and very-late-onset MG…

Read more

300×250 Ad Slot